India's Strides Pharma gains on posting Q2 profit
** Shares of Strides Pharma Science SRID.NS rise 2.5% to
1,599.5 rupees
** The pharma co posted a consolidated net profit of 932.3
mln rupees ($11 mln) vs a loss of 1.31 bln rupees a year ago
** Rev from ops rose 20% Y/Y
** More than 385,000 shares change hands, 1.1x its 30 day
avg
** Stock has surged over two-fold so far this year
($1 = 84.0510 Indian rupees)
(Reporting by Ashna Teresa Britto in Bengaluru)
((AshnaTeresa.Britto@thomsonreuters.com ; ( +91 8078332441))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees